Abstract
Protein polymer hybrids play an increasingly important role in therapeutics and biocatalysis. Synthesis of these biohybrids can be achieved by either the grafting-from or grafting-to strategy and are generally thought to be interchangeable. Therefore, when choosing between these two strategies the decision is usually based on polymer accessibility and purification preference. However, in this study, we demonstrated that the choice of the polymer ligation strategy played a significant role in the stability and bioactivity of the final hybrid. Our goal was to prepare a thermally stable DNase I polymer hybrid by utilizing either synthetic strategies. We found that the grafting-from strategy using reversible addition-fragmentation chain transfer polymerization (RAFT) or atom transfer radical polymerization (ATRP) yielded DNase I biohybrids with no activity. Control reactions were used to demonstrate inherent protein deactivation caused by the grafting-from conditions for either ATRP or RAFT polymerization. The grafting-to method yielded active and thermally stable DNase I biohybrids.
Original language | English |
---|---|
Pages (from-to) | 15-24 |
Number of pages | 10 |
Journal | European Polymer Journal |
Volume | 107 |
DOIs | |
State | Published - Oct 2018 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2018 Elsevier Ltd
Funding
We gratefully acknowledge The Army Research Office (Award# 68271-CH ) Young Investigator Program ( W911NF-17-1-0015 ) and the Neuroscience Institute at AHN for funding NMR measurements and instrumentation at CMU which was partially supported by NSF ( CHE-0130903 and CHE-1039870 ). The MALDI-TOF data were collected using instrumentation purchased with NSF grant award CHE-0839233 . We gratefully acknowledge The Army Research Office (Award# 68271-CH) Young Investigator Program (W911NF-17-1-0015) and the Neuroscience Institute at AHN for funding NMR measurements and instrumentation at CMU which was partially supported by NSF (CHE-0130903 and CHE-1039870). The MALDI-TOF data were collected using instrumentation purchased with NSF grant award CHE-0839233.
Funders | Funder number |
---|---|
Neuroscience Institute | |
National Science Foundation | CHE-1039870, CHE-0130903 |
Army Research Office | W911NF-17-1-0015, 68271-CH |
Carnegie Mellon University | |
National Science Foundation | CHE-0839233 |
Keywords
- Biohybrids
- DNase I
- Grafting-from
- Grafting-to
- Protein polymer hybrids